Abeona Therapeutics Inc (ABEO) financials · rev $5.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Abeona Therapeutics Inc (ABEO) rev $5.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $5.82M | $4.25M |
| Cost of Revenue | $1.53M | N/A |
| Gross Profit | $4.29M | N/A |
| Operating Income | -$89.4M | -$64.2M |
| Net Income | $71.2M | -$63.7M |
| EPS (Diluted) | $1.01 | -$1.55 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $219.6M | $108.9M |
| Current Assets | $204.9M | $100.9M |
| Cash & Equivalents | $78.4M | $23.4M |
| Inventory | $5.49M | N/A |
| PP&E | $9.92M | $4.43M |
| Total Liabilities | $60.4M | $64.9M |
| Current Liabilities | $29.6M | $16.6M |
| Short-term Debt | $12.2M | $5.93M |
| Long-term Debt | $7.81M | $13.0M |
| Total Debt | $20.0M† | $19.0M† |
| Shareholders' Equity | $159.2M | $44.0M |
| Retained Earnings | -$742.1M | -$813.3M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$76.3M | -$56.0M |
| CapEx | $7.97M | $2.45M |
| Investing Cash Flow | $105.0M | -$39.2M |
| Financing Cash Flow | $26.0M | $104.1M |
| Net Change in Cash | $54.7M | $8.88M |
| Free Cash Flow | -$84.3M | -$58.5M |
FAQ
What is ABEO P/E and revenue?
Abeona Therapeutics Inc (ABEO) rev $5.8M.
What is ABEO revenue?
Abeona Therapeutics Inc last cached revenue is $5.82M (FY2025).
Is ABEO profitable?
Abeona Therapeutics Inc last cached net income is $71.2M (FY2025).
What are ABEO total assets?
Abeona Therapeutics Inc last cached total assets are $219.6M (FY2025).
What is ABEO free cash flow?
Abeona Therapeutics Inc last cached free cash flow is -$84.3M (FY2025).
Not investment advice. Cached statements, not a live tape.